| 2026-03-13 |
股东大会：
将于2026-04-29召开股东大会
会议内容 ▼▲
- 1.Elect two directors named in the Proxy Statement to serve on the Board of Directors until Ducommun’s 2029 Annual Meeting of Shareholders and until their successors have been duly elected and qualified, subject to their earlier death, resignation or removal
2.Approve Ducommun’s executive compensation on an advisory basis
3.Ratify the selection of PricewaterhouseCoopers LLP as Ducommun’s independent registered public accounting firm for the year ending December 31, 2026
4.Approve an amendment and restatement of Ducommun’s 2024 Stock Incentive Plan
5.Transact any other business as may properly come before the meeting or any adjournment thereof
|
| 2026-03-10 |
详情>>
内部人交易：
Mookerji Suman B.等共交易2笔
|
| 2026-02-26 |
详情>>
股本变动：
变动后总股本1498.69万股
|
| 2026-02-26 |
详情>>
业绩披露：
2025年年报每股收益-2.27美元,归母净利润-3393.8万美元,同比去年增长-207.76%
|
| 2026-02-26 |
财报披露：
美东时间 2026-02-26 盘前发布财报
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.77美元,归母净利润-4138.2万美元,同比去年增长-267.4%
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益1.55美元,归母净利润2306.40万美元,同比去年增长58.27%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益0.71美元,归母净利润1051.10万美元,同比去年增长53.47%
|
| 2025-03-14 |
股东大会：
将于2025-04-30召开股东大会
会议内容 ▼▲
- 1.Election of two directors named in this Proxy Statement to serve on the Board of Directors until Ducommun’s 2028 Annual Meeting of Shareholders and until their successors have been duly elected and qualified, subject to their earlier, death, resignation or removal;
2.Approval of Ducommun’s executive compensation on an advisory basis;
3.Ratification of the selection of PricewaterhouseCoopers LLP as Ducommun’s independent registered public accounting firm for the year ending December 31, 2025.
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益2.38美元,归母净利润2878.90万美元,同比去年增长-78.76%
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益2.13美元,归母净利润3149.50万美元,同比去年增长97.73%
|
| 2024-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.81美元,归母净利润1081.80万美元,同比去年增长-47.76%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.68美元,归母净利润2472.10万美元,同比去年增长128.52%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益0.99美元,归母净利润1457.30万美元,同比去年增长91.62%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.47美元,归母净利润684.90万美元,同比去年增长30.93%
|
| 2024-04-16 |
复牌提示：
2024-04-16 08:18:31 停牌，复牌日期 2024-04-16 08:42:55
|
| 2024-03-13 |
股东大会：
将于2024-04-24召开股东大会
会议内容 ▼▲
- 1.Elect three directors named in the Proxy Statement to serve on the Board of Directors until Ducommun’s 2027 Annual Meeting of Shareholders and until their successors have been duly elected and qualified, subject to their earlier death, resignation or removal
2.Approve Ducommun’s executive compensation on an advisory basis
3.Approve the Company’s 2024 Stock Incentive Plan
4.Ratify the selection of PricewaterhouseCoopers LLP as Ducommun’s independent registered public accounting firm for the year ending December 31, 2024
5.Transact any other business as may properly come before the meeting or any adjournment thereof
|
| 2024-02-22 |
详情>>
业绩披露：
2023年年报每股收益1.16美元,归母净利润1592.80万美元,同比去年增长-44.67%
|
| 2023-03-14 |
股东大会：
将于2023-04-26召开股东大会
会议内容 ▼▲
- 1.Elect three directors named in the Proxy Statement to serve on the Board of Directors until Ducommun’s 2026 Annual Meeting of Shareholders and until their successors have been duly elected and qualified, subject to their earlier death, resignation or removal
2.Approve Ducommun’s executive compensation on an advisory basis
3.Approve the frequency of future advisory votes on executive compensation on an advisory basis
4.Ratify the selection of PricewaterhouseCoopers LLP as Ducommun’s independent registered public accounting firm for the year ending December 31, 2023
5.Transact any other business as may properly come before the meeting or any adjournment thereof
|
| 2022-03-09 |
股东大会：
将于2022-04-20召开股东大会
会议内容 ▼▲
- 1.Elect two directors named in the Proxy Statement to serve on the Board of Directors until Ducommun’s 2025 Annual Meeting of Shareholders and until their successors have been duly elected and qualified, subject to their earlier death, resignation or removal
2.Ratify the election of one director named in the Proxy Statement to serve on the Board of Directors until Ducommun’s 2024 Annual Meeting of Shareholders and until his successor has been duly elected and qualified, subject to his earlier death, resignation or removal
3.Approve Ducommun’s executive compensation on an advisory basis
4.Approve a proposed amendment and restatement of Ducommun’s 2020 Stock Incentive Plan
5.Ratify the selection of PricewaterhouseCoopers LLP as Ducommun’s independent registered public accounting firm for the year ending December 31, 2022
6.Transact any other business as may properly come before the meeting or any adjournment thereof
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-08 |
股东大会：
将于2021-04-21召开股东大会
会议内容 ▼▲
- 1.The election of the one director named in the Proxy Statement to serve on the Board of Directors until the Company’s 2024 Annual Meeting of Shareholders and until her successor has been elected and qualified;
2.Approve the Company’s executive compensation on an advisory basis;
3.Ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s year ending December 31, 2021;
4.Transact any other business as may properly come before the meeting or any adjournment thereof.
|
| 2020-03-20 |
股东大会：
将于2020-05-06召开股东大会
会议内容 ▼▲
- 1.The election of the two directors named in the Proxy Statement to serve on the Board of Directors until the Company’s 2023 Annual Meeting of Shareholders and until their successors have been elected and qualified;
2.Approve the Company’s executive compensation on an advisory basis;
3.Approve the Company’s 2020 Stock Incentive Plan
4.Ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s year ending December 31, 2020;
5.Transact any other business as may properly come before the meeting or any adjournment thereof.
|
| 2019-03-20 |
股东大会：
将于2019-05-01召开股东大会
会议内容 ▼▲
- 1.Elect the three directors named in the Proxy Statement to serve on the Board of Directors until the Company’s 2022 Annual Meeting of Shareholders and until their successors have been elected and qualified;
2.Approve the Company’s executive compensation on an advisory basis;
3.Ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s year ending December 31, 2019;
4.Transact any other business as may properly come before the meeting or any adjournment thereof.
|
| 2018-03-23 |
股东大会：
将于2018-05-02召开股东大会
会议内容 ▼▲
- 1.Elect the one director named in the Proxy Statement to serve on the Board of Directors until the Company’s 2021 Annual Meeting of Shareholders and until his successor has been elected and qualified;
2.Approve the Company’s executive compensation on an advisory basis;
3.Consider and act upon a proposed amendment and restatement of the 2013 Stock Incentive Plan;
4.Consider and act upon a proposed employee stock purchase plan;
5.Ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s year ending December 31, 2018;
6.Transact any other business as may properly come before the meeting or any adjournment thereof.
|
| 2017-03-30 |
股东大会：
将于2017-05-03召开股东大会
会议内容 ▼▲
- 1.To elect three directors to serve for three-year terms ending in 2020;
2.To vote, on an advisory basis, to approve named executive officer compensation;
3.To vote, on an advisory basis, on the frequency of future advisory votes on named executive officer compensation;
4.To ratify the selection of PricewaterhouseCoopers LLP as the Corporation’s independent registered public accounting firm for the Corporation’s year ending December 31, 2017;
5.To transact any other business that may properly be brought before the meeting or any adjournments or postponements thereof.
|
| 2016-03-31 |
股东大会：
将于2016-05-04召开股东大会
会议内容 ▼▲
- 1. To elect three directors to serve for three-year terms ending in 2019.
2. To provide an advisory vote to approve named executive officer compensation.
3. To ratify the selection of PricewaterhouseCoopers LLP as the Corporation’s independent registered public accounting firm for the Corporation’s fiscal year ending December 31, 2016.
4. To transact any other business that may properly be brought before the meeting or any adjournments or postponements thereof.
|
| 2011-02-10 |
除权日：
美东时间 2011-02-16 每股派息0.08美元
|
| 2010-11-08 |
除权日：
美东时间 2010-11-17 每股派息0.08美元
|
| 2010-07-30 |
除权日：
美东时间 2010-08-18 每股派息0.08美元
|
| 2010-05-06 |
除权日：
美东时间 2010-05-19 每股派息0.08美元
|